nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—Cytochrome P450 2C19 Inducers—Carbamazepine—epilepsy syndrome	0.108	0.202	CiPCiCtD
Enzalutamide—Cytochrome P450 2C9 Inducers—Carbamazepine—epilepsy syndrome	0.108	0.202	CiPCiCtD
Enzalutamide—Cytochrome P450 2C19 Inducers—Phenytoin—epilepsy syndrome	0.0963	0.18	CiPCiCtD
Enzalutamide—Cytochrome P450 2C9 Inducers—Phenytoin—epilepsy syndrome	0.0963	0.18	CiPCiCtD
Enzalutamide—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.0675	0.127	CiPCiCtD
Enzalutamide—Cytochrome P450 3A4 Inducers—Topiramate—epilepsy syndrome	0.0574	0.108	CiPCiCtD
Enzalutamide—CYP2C19—epilepsy syndrome	0.0487	0.354	CbGaD
Enzalutamide—CYP2D6—epilepsy syndrome	0.0361	0.262	CbGaD
Enzalutamide—ALB—epilepsy syndrome	0.027	0.196	CbGaD
Enzalutamide—ABCB1—epilepsy syndrome	0.0258	0.187	CbGaD
Enzalutamide—ALB—Oxcarbazepine—epilepsy syndrome	0.00732	0.0298	CbGbCtD
Enzalutamide—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00653	0.0266	CbGbCtD
Enzalutamide—ALB—Fosphenytoin—epilepsy syndrome	0.0064	0.026	CbGbCtD
Enzalutamide—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00589	0.024	CbGbCtD
Enzalutamide—ALB—Clonazepam—epilepsy syndrome	0.00579	0.0236	CbGbCtD
Enzalutamide—CYP2B6—Clobazam—epilepsy syndrome	0.00566	0.023	CbGbCtD
Enzalutamide—CYP2C8—Trimethadione—epilepsy syndrome	0.00526	0.0214	CbGbCtD
Enzalutamide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00495	0.0201	CbGbCtD
Enzalutamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00475	0.0193	CbGbCtD
Enzalutamide—ALB—Rufinamide—epilepsy syndrome	0.00472	0.0192	CbGbCtD
Enzalutamide—CYP2B6—Carbamazepine—epilepsy syndrome	0.00469	0.0191	CbGbCtD
Enzalutamide—CYP2C19—Trimethadione—epilepsy syndrome	0.00441	0.018	CbGbCtD
Enzalutamide—CYP2C19—Felbamate—epilepsy syndrome	0.00441	0.018	CbGbCtD
Enzalutamide—CYP2B6—Primidone—epilepsy syndrome	0.00438	0.0178	CbGbCtD
Enzalutamide—CYP2B6—Phenytoin—epilepsy syndrome	0.00421	0.0171	CbGbCtD
Enzalutamide—ABCB1—Levetiracetam—epilepsy syndrome	0.00419	0.017	CbGbCtD
Enzalutamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00415	0.0169	CbGbCtD
Enzalutamide—ALB—Phenytoin—epilepsy syndrome	0.00412	0.0168	CbGbCtD
Enzalutamide—CYP2B6—Propofol—epilepsy syndrome	0.00393	0.016	CbGbCtD
Enzalutamide—ALB—Propofol—epilepsy syndrome	0.00385	0.0157	CbGbCtD
Enzalutamide—CYP2B6—Phenobarbital—epilepsy syndrome	0.00375	0.0153	CbGbCtD
Enzalutamide—CYP2B6—Midazolam—epilepsy syndrome	0.0037	0.0151	CbGbCtD
Enzalutamide—CYP3A5—Carbamazepine—epilepsy syndrome	0.0037	0.015	CbGbCtD
Enzalutamide—CYP2C9—Trimethadione—epilepsy syndrome	0.00367	0.0149	CbGbCtD
Enzalutamide—CYP2C19—Clobazam—epilepsy syndrome	0.0036	0.0146	CbGbCtD
Enzalutamide—CYP2B6—Diazepam—epilepsy syndrome	0.00356	0.0145	CbGbCtD
Enzalutamide—CYP2C8—Carbamazepine—epilepsy syndrome	0.00355	0.0145	CbGbCtD
Enzalutamide—ALB—Diazepam—epilepsy syndrome	0.00349	0.0142	CbGbCtD
Enzalutamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00345	0.014	CbGbCtD
Enzalutamide—CYP2C8—Primidone—epilepsy syndrome	0.00332	0.0135	CbGbCtD
Enzalutamide—CYP3A5—Phenytoin—epilepsy syndrome	0.00332	0.0135	CbGbCtD
Enzalutamide—CYP2C8—Phenytoin—epilepsy syndrome	0.00319	0.013	CbGbCtD
Enzalutamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00298	0.0121	CbGbCtD
Enzalutamide—CYP2C8—Propofol—epilepsy syndrome	0.00297	0.0121	CbGbCtD
Enzalutamide—CYP3A5—Phenobarbital—epilepsy syndrome	0.00295	0.012	CbGbCtD
Enzalutamide—CYP3A5—Midazolam—epilepsy syndrome	0.00291	0.0119	CbGbCtD
Enzalutamide—ABCB1—Clobazam—epilepsy syndrome	0.0029	0.0118	CbGbCtD
Enzalutamide—CYP2C8—Phenobarbital—epilepsy syndrome	0.00284	0.0116	CbGbCtD
Enzalutamide—CYP2B6—Valproic Acid—epilepsy syndrome	0.0028	0.0114	CbGbCtD
Enzalutamide—CYP3A5—Diazepam—epilepsy syndrome	0.0028	0.0114	CbGbCtD
Enzalutamide—ABCB1—Lamotrigine—epilepsy syndrome	0.00279	0.0114	CbGbCtD
Enzalutamide—CYP2C19—Primidone—epilepsy syndrome	0.00278	0.0113	CbGbCtD
Enzalutamide—CYP2C8—Diazepam—epilepsy syndrome	0.00269	0.011	CbGbCtD
Enzalutamide—CYP2C19—Phenytoin—epilepsy syndrome	0.00267	0.0109	CbGbCtD
Enzalutamide—CYP2C19—Propofol—epilepsy syndrome	0.00249	0.0101	CbGbCtD
Enzalutamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00248	0.0101	CbGbCtD
Enzalutamide—ABCB1—Carbamazepine—epilepsy syndrome	0.00241	0.00979	CbGbCtD
Enzalutamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00238	0.0097	CbGbCtD
Enzalutamide—CYP2C9—Primidone—epilepsy syndrome	0.00231	0.00942	CbGbCtD
Enzalutamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0023	0.00934	CbGbCtD
Enzalutamide—CYP2C19—Diazepam—epilepsy syndrome	0.00226	0.0092	CbGbCtD
Enzalutamide—CYP2C9—Phenytoin—epilepsy syndrome	0.00222	0.00905	CbGbCtD
Enzalutamide—CYP3A5—Valproic Acid—epilepsy syndrome	0.00221	0.00899	CbGbCtD
Enzalutamide—CYP2C19—Zonisamide—epilepsy syndrome	0.00221	0.00897	CbGbCtD
Enzalutamide—ABCB1—Phenytoin—epilepsy syndrome	0.00216	0.00878	CbGbCtD
Enzalutamide—CYP3A4—Felbamate—epilepsy syndrome	0.00213	0.00868	CbGbCtD
Enzalutamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00213	0.00868	CbGbCtD
Enzalutamide—CYP2C8—Valproic Acid—epilepsy syndrome	0.00212	0.00864	CbGbCtD
Enzalutamide—CYP2C9—Propofol—epilepsy syndrome	0.00207	0.00844	CbGbCtD
Enzalutamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00201	0.00816	CbGbCtD
Enzalutamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00198	0.00806	CbGbCtD
Enzalutamide—ABCB1—Phenobarbital—epilepsy syndrome	0.00192	0.00783	CbGbCtD
Enzalutamide—ABCB1—Midazolam—epilepsy syndrome	0.0019	0.00772	CbGbCtD
Enzalutamide—CYP2D6—Propofol—epilepsy syndrome	0.0019	0.00772	CbGbCtD
Enzalutamide—CYP2C9—Diazepam—epilepsy syndrome	0.00188	0.00764	CbGbCtD
Enzalutamide—ABCB1—Diazepam—epilepsy syndrome	0.00182	0.00742	CbGbCtD
Enzalutamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00181	0.00738	CbGbCtD
Enzalutamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00178	0.00725	CbGbCtD
Enzalutamide—CYP3A4—Clobazam—epilepsy syndrome	0.00174	0.00708	CbGbCtD
Enzalutamide—CYP2C19—Topiramate—epilepsy syndrome	0.00161	0.00654	CbGbCtD
Enzalutamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00148	0.00603	CbGbCtD
Enzalutamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00148	0.00602	CbGbCtD
Enzalutamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00144	0.00587	CbGbCtD
Enzalutamide—CYP3A4—Primidone—epilepsy syndrome	0.00135	0.00548	CbGbCtD
Enzalutamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00129	0.00526	CbGbCtD
Enzalutamide—CYP3A4—Propofol—epilepsy syndrome	0.00121	0.00491	CbGbCtD
Enzalutamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00115	0.00469	CbGbCtD
Enzalutamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00115	0.00469	CbGbCtD
Enzalutamide—CYP3A4—Midazolam—epilepsy syndrome	0.00114	0.00462	CbGbCtD
Enzalutamide—CYP3A4—Diazepam—epilepsy syndrome	0.00109	0.00445	CbGbCtD
Enzalutamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00107	0.00434	CbGbCtD
Enzalutamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000861	0.0035	CbGbCtD
Enzalutamide—CYP3A4—Topiramate—epilepsy syndrome	0.000777	0.00316	CbGbCtD
Enzalutamide—Bicalutamide—CYP2C19—epilepsy syndrome	0.000452	0.419	CrCbGaD
Enzalutamide—Bicalutamide—CYP2D6—epilepsy syndrome	0.000335	0.311	CrCbGaD
Enzalutamide—Nilutamide—CYP2C19—epilepsy syndrome	0.000292	0.27	CrCbGaD
Enzalutamide—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	5.41e-05	0.000871	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	5.4e-05	0.00087	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	5.37e-05	0.000865	CcSEcCtD
Enzalutamide—Skin disorder—Oxcarbazepine—epilepsy syndrome	5.37e-05	0.000865	CcSEcCtD
Enzalutamide—Fatigue—Vigabatrin—epilepsy syndrome	5.36e-05	0.000864	CcSEcCtD
Enzalutamide—Insomnia—Felbamate—epilepsy syndrome	5.36e-05	0.000864	CcSEcCtD
Enzalutamide—Arthralgia—Lamotrigine—epilepsy syndrome	5.35e-05	0.000861	CcSEcCtD
Enzalutamide—Headache—Lacosamide—epilepsy syndrome	5.34e-05	0.00086	CcSEcCtD
Enzalutamide—Anxiety—Lamotrigine—epilepsy syndrome	5.33e-05	0.000858	CcSEcCtD
Enzalutamide—Pneumonia—Gabapentin—epilepsy syndrome	5.32e-05	0.000858	CcSEcCtD
Enzalutamide—Paraesthesia—Felbamate—epilepsy syndrome	5.32e-05	0.000857	CcSEcCtD
Enzalutamide—Infestation NOS—Gabapentin—epilepsy syndrome	5.29e-05	0.000853	CcSEcCtD
Enzalutamide—Infestation—Gabapentin—epilepsy syndrome	5.29e-05	0.000853	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Diazepam—epilepsy syndrome	5.29e-05	0.000852	CcSEcCtD
Enzalutamide—Asthenia—Acetazolamide—epilepsy syndrome	5.29e-05	0.000852	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	5.29e-05	0.000852	CcSEcCtD
Enzalutamide—Fatigue—Diazepam—epilepsy syndrome	5.28e-05	0.000851	CcSEcCtD
Enzalutamide—Infection—Carbamazepine—epilepsy syndrome	5.27e-05	0.000849	CcSEcCtD
Enzalutamide—Insomnia—Zonisamide—epilepsy syndrome	5.25e-05	0.000845	CcSEcCtD
Enzalutamide—Paraesthesia—Zonisamide—epilepsy syndrome	5.21e-05	0.000839	CcSEcCtD
Enzalutamide—Angiopathy—Valproic Acid—epilepsy syndrome	5.2e-05	0.000838	CcSEcCtD
Enzalutamide—Nervous system disorder—Carbamazepine—epilepsy syndrome	5.2e-05	0.000838	CcSEcCtD
Enzalutamide—Rhinitis—Pregabalin—epilepsy syndrome	5.2e-05	0.000837	CcSEcCtD
Enzalutamide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	5.19e-05	0.000836	CcSEcCtD
Enzalutamide—Headache—Clobazam—epilepsy syndrome	5.18e-05	0.000834	CcSEcCtD
Enzalutamide—Nasopharyngitis—Topiramate—epilepsy syndrome	5.17e-05	0.000832	CcSEcCtD
Enzalutamide—Hypoaesthesia—Pregabalin—epilepsy syndrome	5.16e-05	0.000831	CcSEcCtD
Enzalutamide—Skin disorder—Carbamazepine—epilepsy syndrome	5.15e-05	0.00083	CcSEcCtD
Enzalutamide—Pharyngitis—Pregabalin—epilepsy syndrome	5.14e-05	0.000828	CcSEcCtD
Enzalutamide—Urinary tract disorder—Pregabalin—epilepsy syndrome	5.12e-05	0.000824	CcSEcCtD
Enzalutamide—Fatigue—Felbamate—epilepsy syndrome	5.11e-05	0.000823	CcSEcCtD
Enzalutamide—Oedema peripheral—Pregabalin—epilepsy syndrome	5.11e-05	0.000822	CcSEcCtD
Enzalutamide—Muscular weakness—Topiramate—epilepsy syndrome	5.1e-05	0.000821	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	5.1e-05	0.000821	CcSEcCtD
Enzalutamide—Connective tissue disorder—Pregabalin—epilepsy syndrome	5.09e-05	0.00082	CcSEcCtD
Enzalutamide—Infection—Lamotrigine—epilepsy syndrome	5.09e-05	0.00082	CcSEcCtD
Enzalutamide—Urethral disorder—Pregabalin—epilepsy syndrome	5.08e-05	0.000818	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	5.06e-05	0.000815	CcSEcCtD
Enzalutamide—Insomnia—Clonazepam—epilepsy syndrome	5.06e-05	0.000815	CcSEcCtD
Enzalutamide—Haematuria—Gabapentin—epilepsy syndrome	5.05e-05	0.000813	CcSEcCtD
Enzalutamide—Diarrhoea—Acetazolamide—epilepsy syndrome	5.04e-05	0.000812	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000811	CcSEcCtD
Enzalutamide—Nervous system disorder—Lamotrigine—epilepsy syndrome	5.03e-05	0.00081	CcSEcCtD
Enzalutamide—Insomnia—Phenytoin—epilepsy syndrome	5.02e-05	0.000809	CcSEcCtD
Enzalutamide—Mental disorder—Valproic Acid—epilepsy syndrome	5.02e-05	0.000809	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	5.02e-05	0.000808	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	5.01e-05	0.000807	CcSEcCtD
Enzalutamide—Fatigue—Zonisamide—epilepsy syndrome	5e-05	0.000806	CcSEcCtD
Enzalutamide—Insomnia—Oxcarbazepine—epilepsy syndrome	5e-05	0.000805	CcSEcCtD
Enzalutamide—Epistaxis—Gabapentin—epilepsy syndrome	4.99e-05	0.000804	CcSEcCtD
Enzalutamide—Paraesthesia—Phenytoin—epilepsy syndrome	4.99e-05	0.000803	CcSEcCtD
Enzalutamide—Sinusitis—Gabapentin—epilepsy syndrome	4.97e-05	0.0008	CcSEcCtD
Enzalutamide—Asthenia—Propofol—epilepsy syndrome	4.91e-05	0.000791	CcSEcCtD
Enzalutamide—Dizziness—Acetazolamide—epilepsy syndrome	4.87e-05	0.000785	CcSEcCtD
Enzalutamide—Pruritus—Propofol—epilepsy syndrome	4.84e-05	0.00078	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	4.83e-05	0.000778	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	4.83e-05	0.000778	CcSEcCtD
Enzalutamide—Back pain—Valproic Acid—epilepsy syndrome	4.83e-05	0.000777	CcSEcCtD
Enzalutamide—Fatigue—Clonazepam—epilepsy syndrome	4.82e-05	0.000777	CcSEcCtD
Enzalutamide—Asthenia—Midazolam—epilepsy syndrome	4.81e-05	0.000774	CcSEcCtD
Enzalutamide—Bronchitis—Topiramate—epilepsy syndrome	4.8e-05	0.000774	CcSEcCtD
Enzalutamide—Insomnia—Carbamazepine—epilepsy syndrome	4.8e-05	0.000773	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	4.8e-05	0.000773	CcSEcCtD
Enzalutamide—Fatigue—Phenytoin—epilepsy syndrome	4.79e-05	0.000771	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	4.77e-05	0.000768	CcSEcCtD
Enzalutamide—Fatigue—Oxcarbazepine—epilepsy syndrome	4.76e-05	0.000767	CcSEcCtD
Enzalutamide—Rhinitis—Gabapentin—epilepsy syndrome	4.76e-05	0.000767	CcSEcCtD
Enzalutamide—Paraesthesia—Carbamazepine—epilepsy syndrome	4.76e-05	0.000767	CcSEcCtD
Enzalutamide—Asthenia—Levetiracetam—epilepsy syndrome	4.75e-05	0.000764	CcSEcCtD
Enzalutamide—Pruritus—Midazolam—epilepsy syndrome	4.74e-05	0.000763	CcSEcCtD
Enzalutamide—Hypoaesthesia—Gabapentin—epilepsy syndrome	4.73e-05	0.000762	CcSEcCtD
Enzalutamide—Pharyngitis—Gabapentin—epilepsy syndrome	4.72e-05	0.00076	CcSEcCtD
Enzalutamide—Angiopathy—Pregabalin—epilepsy syndrome	4.7e-05	0.000757	CcSEcCtD
Enzalutamide—Urinary tract disorder—Gabapentin—epilepsy syndrome	4.69e-05	0.000756	CcSEcCtD
Enzalutamide—Diarrhoea—Propofol—epilepsy syndrome	4.68e-05	0.000754	CcSEcCtD
Enzalutamide—Oedema peripheral—Gabapentin—epilepsy syndrome	4.68e-05	0.000754	CcSEcCtD
Enzalutamide—Pruritus—Levetiracetam—epilepsy syndrome	4.68e-05	0.000754	CcSEcCtD
Enzalutamide—Neutropenia—Topiramate—epilepsy syndrome	4.67e-05	0.000752	CcSEcCtD
Enzalutamide—Connective tissue disorder—Gabapentin—epilepsy syndrome	4.67e-05	0.000752	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	4.67e-05	0.000752	CcSEcCtD
Enzalutamide—Urethral disorder—Gabapentin—epilepsy syndrome	4.66e-05	0.00075	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Topiramate—epilepsy syndrome	4.64e-05	0.000748	CcSEcCtD
Enzalutamide—Insomnia—Lamotrigine—epilepsy syndrome	4.64e-05	0.000747	CcSEcCtD
Enzalutamide—Headache—Acetazolamide—epilepsy syndrome	4.62e-05	0.000744	CcSEcCtD
Enzalutamide—Pollakiuria—Topiramate—epilepsy syndrome	4.61e-05	0.000743	CcSEcCtD
Enzalutamide—Paraesthesia—Lamotrigine—epilepsy syndrome	4.6e-05	0.000741	CcSEcCtD
Enzalutamide—Asthenia—Fosphenytoin—epilepsy syndrome	4.58e-05	0.000738	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	4.58e-05	0.000737	CcSEcCtD
Enzalutamide—Fatigue—Carbamazepine—epilepsy syndrome	4.57e-05	0.000736	CcSEcCtD
Enzalutamide—Mental disorder—Pregabalin—epilepsy syndrome	4.54e-05	0.000731	CcSEcCtD
Enzalutamide—Dizziness—Propofol—epilepsy syndrome	4.53e-05	0.000729	CcSEcCtD
Enzalutamide—Diarrhoea—Levetiracetam—epilepsy syndrome	4.53e-05	0.000729	CcSEcCtD
Enzalutamide—Pruritus—Fosphenytoin—epilepsy syndrome	4.52e-05	0.000727	CcSEcCtD
Enzalutamide—Vertigo—Valproic Acid—epilepsy syndrome	4.48e-05	0.000722	CcSEcCtD
Enzalutamide—Pneumonia—Topiramate—epilepsy syndrome	4.48e-05	0.000721	CcSEcCtD
Enzalutamide—Leukopenia—Valproic Acid—epilepsy syndrome	4.47e-05	0.000719	CcSEcCtD
Enzalutamide—Asthenia—Vigabatrin—epilepsy syndrome	4.46e-05	0.000719	CcSEcCtD
Enzalutamide—Infestation—Topiramate—epilepsy syndrome	4.45e-05	0.000717	CcSEcCtD
Enzalutamide—Infestation NOS—Topiramate—epilepsy syndrome	4.45e-05	0.000717	CcSEcCtD
Enzalutamide—Dizziness—Midazolam—epilepsy syndrome	4.43e-05	0.000713	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.42e-05	0.000713	CcSEcCtD
Enzalutamide—Fatigue—Lamotrigine—epilepsy syndrome	4.42e-05	0.000712	CcSEcCtD
Enzalutamide—Pruritus—Vigabatrin—epilepsy syndrome	4.4e-05	0.000709	CcSEcCtD
Enzalutamide—Asthenia—Diazepam—epilepsy syndrome	4.39e-05	0.000708	CcSEcCtD
Enzalutamide—Dizziness—Levetiracetam—epilepsy syndrome	4.37e-05	0.000704	CcSEcCtD
Enzalutamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.37e-05	0.000703	CcSEcCtD
Enzalutamide—Back pain—Pregabalin—epilepsy syndrome	4.36e-05	0.000703	CcSEcCtD
Enzalutamide—Pruritus—Diazepam—epilepsy syndrome	4.33e-05	0.000698	CcSEcCtD
Enzalutamide—Hypertension—Valproic Acid—epilepsy syndrome	4.31e-05	0.000694	CcSEcCtD
Enzalutamide—Headache—Propofol—epilepsy syndrome	4.29e-05	0.000691	CcSEcCtD
Enzalutamide—Diarrhoea—Vigabatrin—epilepsy syndrome	4.26e-05	0.000686	CcSEcCtD
Enzalutamide—Asthenia—Felbamate—epilepsy syndrome	4.25e-05	0.000685	CcSEcCtD
Enzalutamide—Arthralgia—Valproic Acid—epilepsy syndrome	4.25e-05	0.000684	CcSEcCtD
Enzalutamide—Haematuria—Topiramate—epilepsy syndrome	4.25e-05	0.000684	CcSEcCtD
Enzalutamide—Anxiety—Valproic Acid—epilepsy syndrome	4.23e-05	0.000682	CcSEcCtD
Enzalutamide—Dizziness—Fosphenytoin—epilepsy syndrome	4.22e-05	0.00068	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.22e-05	0.00068	CcSEcCtD
Enzalutamide—Epistaxis—Topiramate—epilepsy syndrome	4.2e-05	0.000677	CcSEcCtD
Enzalutamide—Headache—Midazolam—epilepsy syndrome	4.2e-05	0.000676	CcSEcCtD
Enzalutamide—Pruritus—Felbamate—epilepsy syndrome	4.19e-05	0.000676	CcSEcCtD
Enzalutamide—Diarrhoea—Diazepam—epilepsy syndrome	4.19e-05	0.000675	CcSEcCtD
Enzalutamide—Sinusitis—Topiramate—epilepsy syndrome	4.18e-05	0.000673	CcSEcCtD
Enzalutamide—Asthenia—Zonisamide—epilepsy syndrome	4.16e-05	0.000671	CcSEcCtD
Enzalutamide—Mental disorder—Gabapentin—epilepsy syndrome	4.16e-05	0.000671	CcSEcCtD
Enzalutamide—Headache—Levetiracetam—epilepsy syndrome	4.14e-05	0.000667	CcSEcCtD
Enzalutamide—Dizziness—Vigabatrin—epilepsy syndrome	4.11e-05	0.000663	CcSEcCtD
Enzalutamide—Pruritus—Zonisamide—epilepsy syndrome	4.11e-05	0.000661	CcSEcCtD
Enzalutamide—Diarrhoea—Felbamate—epilepsy syndrome	4.06e-05	0.000653	CcSEcCtD
Enzalutamide—Vertigo—Pregabalin—epilepsy syndrome	4.05e-05	0.000653	CcSEcCtD
Enzalutamide—Dizziness—Diazepam—epilepsy syndrome	4.05e-05	0.000652	CcSEcCtD
Enzalutamide—Infection—Valproic Acid—epilepsy syndrome	4.05e-05	0.000652	CcSEcCtD
Enzalutamide—Leukopenia—Pregabalin—epilepsy syndrome	4.04e-05	0.00065	CcSEcCtD
Enzalutamide—Asthenia—Clonazepam—epilepsy syndrome	4.01e-05	0.000646	CcSEcCtD
Enzalutamide—Rhinitis—Topiramate—epilepsy syndrome	4.01e-05	0.000646	CcSEcCtD
Enzalutamide—Back pain—Gabapentin—epilepsy syndrome	4e-05	0.000644	CcSEcCtD
Enzalutamide—Headache—Fosphenytoin—epilepsy syndrome	4e-05	0.000644	CcSEcCtD
Enzalutamide—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.99e-05	0.000643	CcSEcCtD
Enzalutamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.99e-05	0.000642	CcSEcCtD
Enzalutamide—Asthenia—Phenytoin—epilepsy syndrome	3.99e-05	0.000642	CcSEcCtD
Enzalutamide—Hypoaesthesia—Topiramate—epilepsy syndrome	3.98e-05	0.000641	CcSEcCtD
Enzalutamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.97e-05	0.00064	CcSEcCtD
Enzalutamide—Pharyngitis—Topiramate—epilepsy syndrome	3.97e-05	0.000639	CcSEcCtD
Enzalutamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.96e-05	0.000639	CcSEcCtD
Enzalutamide—Pruritus—Clonazepam—epilepsy syndrome	3.96e-05	0.000637	CcSEcCtD
Enzalutamide—Skin disorder—Valproic Acid—epilepsy syndrome	3.96e-05	0.000637	CcSEcCtD
Enzalutamide—Urinary tract disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000636	CcSEcCtD
Enzalutamide—Oedema peripheral—Topiramate—epilepsy syndrome	3.94e-05	0.000634	CcSEcCtD
Enzalutamide—Pruritus—Phenytoin—epilepsy syndrome	3.93e-05	0.000633	CcSEcCtD
Enzalutamide—Connective tissue disorder—Topiramate—epilepsy syndrome	3.93e-05	0.000633	CcSEcCtD
Enzalutamide—Dizziness—Felbamate—epilepsy syndrome	3.92e-05	0.000631	CcSEcCtD
Enzalutamide—Urethral disorder—Topiramate—epilepsy syndrome	3.92e-05	0.000631	CcSEcCtD
Enzalutamide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.91e-05	0.00063	CcSEcCtD
Enzalutamide—Convulsion—Pregabalin—epilepsy syndrome	3.91e-05	0.00063	CcSEcCtD
Enzalutamide—Headache—Vigabatrin—epilepsy syndrome	3.9e-05	0.000628	CcSEcCtD
Enzalutamide—Hypertension—Pregabalin—epilepsy syndrome	3.89e-05	0.000627	CcSEcCtD
Enzalutamide—Arthralgia—Pregabalin—epilepsy syndrome	3.84e-05	0.000619	CcSEcCtD
Enzalutamide—Dizziness—Zonisamide—epilepsy syndrome	3.84e-05	0.000618	CcSEcCtD
Enzalutamide—Headache—Diazepam—epilepsy syndrome	3.84e-05	0.000618	CcSEcCtD
Enzalutamide—Anxiety—Pregabalin—epilepsy syndrome	3.83e-05	0.000616	CcSEcCtD
Enzalutamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.83e-05	0.000616	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.81e-05	0.000614	CcSEcCtD
Enzalutamide—Asthenia—Carbamazepine—epilepsy syndrome	3.8e-05	0.000613	CcSEcCtD
Enzalutamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.8e-05	0.000612	CcSEcCtD
Enzalutamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.78e-05	0.000609	CcSEcCtD
Enzalutamide—Pruritus—Carbamazepine—epilepsy syndrome	3.75e-05	0.000604	CcSEcCtD
Enzalutamide—Vertigo—Gabapentin—epilepsy syndrome	3.72e-05	0.000599	CcSEcCtD
Enzalutamide—Headache—Felbamate—epilepsy syndrome	3.71e-05	0.000598	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.71e-05	0.000598	CcSEcCtD
Enzalutamide—Leukopenia—Gabapentin—epilepsy syndrome	3.7e-05	0.000596	CcSEcCtD
Enzalutamide—Dizziness—Clonazepam—epilepsy syndrome	3.7e-05	0.000596	CcSEcCtD
Enzalutamide—Insomnia—Valproic Acid—epilepsy syndrome	3.68e-05	0.000593	CcSEcCtD
Enzalutamide—Asthenia—Lamotrigine—epilepsy syndrome	3.68e-05	0.000592	CcSEcCtD
Enzalutamide—Dizziness—Phenytoin—epilepsy syndrome	3.67e-05	0.000592	CcSEcCtD
Enzalutamide—Infection—Pregabalin—epilepsy syndrome	3.66e-05	0.000589	CcSEcCtD
Enzalutamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.66e-05	0.000589	CcSEcCtD
Enzalutamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.65e-05	0.000589	CcSEcCtD
Enzalutamide—Headache—Zonisamide—epilepsy syndrome	3.64e-05	0.000586	CcSEcCtD
Enzalutamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.63e-05	0.000584	CcSEcCtD
Enzalutamide—Angiopathy—Topiramate—epilepsy syndrome	3.63e-05	0.000584	CcSEcCtD
Enzalutamide—Pruritus—Lamotrigine—epilepsy syndrome	3.63e-05	0.000584	CcSEcCtD
Enzalutamide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.61e-05	0.000582	CcSEcCtD
Enzalutamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.6e-05	0.000581	CcSEcCtD
Enzalutamide—Convulsion—Gabapentin—epilepsy syndrome	3.58e-05	0.000577	CcSEcCtD
Enzalutamide—Skin disorder—Pregabalin—epilepsy syndrome	3.58e-05	0.000576	CcSEcCtD
Enzalutamide—Hypertension—Gabapentin—epilepsy syndrome	3.57e-05	0.000575	CcSEcCtD
Enzalutamide—Arthralgia—Gabapentin—epilepsy syndrome	3.52e-05	0.000567	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.52e-05	0.000566	CcSEcCtD
Enzalutamide—Fatigue—Valproic Acid—epilepsy syndrome	3.51e-05	0.000566	CcSEcCtD
Enzalutamide—Anxiety—Gabapentin—epilepsy syndrome	3.51e-05	0.000565	CcSEcCtD
Enzalutamide—Dizziness—Carbamazepine—epilepsy syndrome	3.51e-05	0.000565	CcSEcCtD
Enzalutamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.51e-05	0.000565	CcSEcCtD
Enzalutamide—Headache—Clonazepam—epilepsy syndrome	3.5e-05	0.000564	CcSEcCtD
Enzalutamide—Mental disorder—Topiramate—epilepsy syndrome	3.5e-05	0.000564	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.5e-05	0.000563	CcSEcCtD
Enzalutamide—Headache—Phenytoin—epilepsy syndrome	3.48e-05	0.000561	CcSEcCtD
Enzalutamide—Headache—Oxcarbazepine—epilepsy syndrome	3.46e-05	0.000558	CcSEcCtD
Enzalutamide—Dizziness—Lamotrigine—epilepsy syndrome	3.39e-05	0.000546	CcSEcCtD
Enzalutamide—Back pain—Topiramate—epilepsy syndrome	3.37e-05	0.000542	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.35e-05	0.00054	CcSEcCtD
Enzalutamide—Infection—Gabapentin—epilepsy syndrome	3.35e-05	0.00054	CcSEcCtD
Enzalutamide—Insomnia—Pregabalin—epilepsy syndrome	3.33e-05	0.000536	CcSEcCtD
Enzalutamide—Headache—Carbamazepine—epilepsy syndrome	3.32e-05	0.000535	CcSEcCtD
Enzalutamide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.31e-05	0.000533	CcSEcCtD
Enzalutamide—Paraesthesia—Pregabalin—epilepsy syndrome	3.31e-05	0.000532	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.31e-05	0.000532	CcSEcCtD
Enzalutamide—Skin disorder—Gabapentin—epilepsy syndrome	3.28e-05	0.000528	CcSEcCtD
Enzalutamide—Headache—Lamotrigine—epilepsy syndrome	3.21e-05	0.000517	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.18e-05	0.000512	CcSEcCtD
Enzalutamide—Fatigue—Pregabalin—epilepsy syndrome	3.17e-05	0.000511	CcSEcCtD
Enzalutamide—Vertigo—Topiramate—epilepsy syndrome	3.13e-05	0.000504	CcSEcCtD
Enzalutamide—Leukopenia—Topiramate—epilepsy syndrome	3.12e-05	0.000502	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.08e-05	0.000495	CcSEcCtD
Enzalutamide—Insomnia—Gabapentin—epilepsy syndrome	3.05e-05	0.000492	CcSEcCtD
Enzalutamide—Paraesthesia—Gabapentin—epilepsy syndrome	3.03e-05	0.000488	CcSEcCtD
Enzalutamide—Convulsion—Topiramate—epilepsy syndrome	3.02e-05	0.000486	CcSEcCtD
Enzalutamide—Hypertension—Topiramate—epilepsy syndrome	3e-05	0.000484	CcSEcCtD
Enzalutamide—Arthralgia—Topiramate—epilepsy syndrome	2.96e-05	0.000477	CcSEcCtD
Enzalutamide—Anxiety—Topiramate—epilepsy syndrome	2.95e-05	0.000476	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.94e-05	0.000474	CcSEcCtD
Enzalutamide—Asthenia—Valproic Acid—epilepsy syndrome	2.92e-05	0.000471	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.91e-05	0.000469	CcSEcCtD
Enzalutamide—Fatigue—Gabapentin—epilepsy syndrome	2.91e-05	0.000469	CcSEcCtD
Enzalutamide—Pruritus—Valproic Acid—epilepsy syndrome	2.88e-05	0.000464	CcSEcCtD
Enzalutamide—Infection—Topiramate—epilepsy syndrome	2.82e-05	0.000455	CcSEcCtD
Enzalutamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.79e-05	0.000449	CcSEcCtD
Enzalutamide—Nervous system disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000449	CcSEcCtD
Enzalutamide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.78e-05	0.000448	CcSEcCtD
Enzalutamide—Skin disorder—Topiramate—epilepsy syndrome	2.76e-05	0.000444	CcSEcCtD
Enzalutamide—Dizziness—Valproic Acid—epilepsy syndrome	2.69e-05	0.000434	CcSEcCtD
Enzalutamide—Asthenia—Pregabalin—epilepsy syndrome	2.64e-05	0.000425	CcSEcCtD
Enzalutamide—Pruritus—Pregabalin—epilepsy syndrome	2.6e-05	0.00042	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.59e-05	0.000417	CcSEcCtD
Enzalutamide—Insomnia—Topiramate—epilepsy syndrome	2.57e-05	0.000414	CcSEcCtD
Enzalutamide—Headache—Valproic Acid—epilepsy syndrome	2.55e-05	0.000411	CcSEcCtD
Enzalutamide—Paraesthesia—Topiramate—epilepsy syndrome	2.55e-05	0.000411	CcSEcCtD
Enzalutamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.52e-05	0.000406	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.45e-05	0.000395	CcSEcCtD
Enzalutamide—Fatigue—Topiramate—epilepsy syndrome	2.45e-05	0.000394	CcSEcCtD
Enzalutamide—Dizziness—Pregabalin—epilepsy syndrome	2.43e-05	0.000392	CcSEcCtD
Enzalutamide—Asthenia—Gabapentin—epilepsy syndrome	2.42e-05	0.00039	CcSEcCtD
Enzalutamide—Pruritus—Gabapentin—epilepsy syndrome	2.39e-05	0.000385	CcSEcCtD
Enzalutamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.31e-05	0.000372	CcSEcCtD
Enzalutamide—Headache—Pregabalin—epilepsy syndrome	2.31e-05	0.000372	CcSEcCtD
Enzalutamide—Dizziness—Gabapentin—epilepsy syndrome	2.23e-05	0.00036	CcSEcCtD
Enzalutamide—Headache—Gabapentin—epilepsy syndrome	2.12e-05	0.000341	CcSEcCtD
Enzalutamide—Asthenia—Topiramate—epilepsy syndrome	2.04e-05	0.000328	CcSEcCtD
Enzalutamide—Pruritus—Topiramate—epilepsy syndrome	2.01e-05	0.000324	CcSEcCtD
Enzalutamide—Diarrhoea—Topiramate—epilepsy syndrome	1.94e-05	0.000313	CcSEcCtD
Enzalutamide—Dizziness—Topiramate—epilepsy syndrome	1.88e-05	0.000303	CcSEcCtD
Enzalutamide—Headache—Topiramate—epilepsy syndrome	1.78e-05	0.000287	CcSEcCtD
Enzalutamide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	2.89e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.89e-06	0.000148	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PLAU—epilepsy syndrome	2.87e-06	0.000147	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	2.87e-06	0.000147	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	2.84e-06	0.000146	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	2.84e-06	0.000146	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	2.84e-06	0.000146	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CHRM3—epilepsy syndrome	2.82e-06	0.000145	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—KCNJ11—epilepsy syndrome	2.82e-06	0.000145	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	2.82e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.81e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.8e-06	0.000144	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.8e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.78e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.78e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.78e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.78e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.78e-06	0.000143	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.77e-06	0.000142	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AQP1—epilepsy syndrome	2.74e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	2.73e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.69e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.67e-06	0.000137	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PRKCB—epilepsy syndrome	2.67e-06	0.000137	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	2.66e-06	0.000137	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.66e-06	0.000136	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	2.65e-06	0.000136	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.64e-06	0.000136	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS2—epilepsy syndrome	2.64e-06	0.000135	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.63e-06	0.000135	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.63e-06	0.000135	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.6e-06	0.000134	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.59e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.59e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.58e-06	0.000132	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.58e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.56e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.54e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.54e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.54e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.53e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.53e-06	0.00013	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.5e-06	0.000128	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.47e-06	0.000127	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.47e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.45e-06	0.000126	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.45e-06	0.000126	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.39e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.37e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.37e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.36e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.34e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.33e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.33e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.31e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.31e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.31e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.31e-06	0.000118	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCG2—epilepsy syndrome	2.3e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.27e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.27e-06	0.000116	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.26e-06	0.000116	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.24e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.24e-06	0.000115	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.23e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.23e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.22e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.22e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.21e-06	0.000114	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.21e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.16e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.16e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.15e-06	0.00011	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.14e-06	0.00011	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TH—epilepsy syndrome	2.13e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.11e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.11e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.11e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.11e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.09e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TH—epilepsy syndrome	2.08e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.07e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.03e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.02e-06	0.000104	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.02e-06	0.000103	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.01e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.01e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.01e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.99e-06	0.000102	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.97e-06	0.000101	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.97e-06	0.000101	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.95e-06	0.0001	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.93e-06	9.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.93e-06	9.87e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.92e-06	9.83e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.92e-06	9.82e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—BCHE—epilepsy syndrome	1.91e-06	9.78e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.9e-06	9.74e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.89e-06	9.69e-05	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.89e-06	9.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.88e-06	9.66e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.86e-06	9.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.86e-06	9.51e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.85e-06	9.49e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.84e-06	9.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.84e-06	9.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.83e-06	9.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.82e-06	9.35e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.82e-06	9.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.81e-06	9.29e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.81e-06	9.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.81e-06	9.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.81e-06	9.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TH—epilepsy syndrome	1.8e-06	9.24e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PLCB1—epilepsy syndrome	1.8e-06	9.22e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TH—epilepsy syndrome	1.79e-06	9.19e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.78e-06	9.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.78e-06	9.1e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.77e-06	9.05e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.76e-06	9.04e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.75e-06	8.99e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	8.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.74e-06	8.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.72e-06	8.81e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.71e-06	8.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.71e-06	8.78e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.71e-06	8.75e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.69e-06	8.64e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.68e-06	8.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.68e-06	8.6e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.67e-06	8.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	8.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.65e-06	8.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.65e-06	8.44e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.63e-06	8.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.62e-06	8.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TH—epilepsy syndrome	1.61e-06	8.25e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.59e-06	8.17e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.59e-06	8.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.58e-06	8.12e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.58e-06	8.11e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.58e-06	8.08e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.57e-06	8.07e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TH—epilepsy syndrome	1.57e-06	8.05e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SRC—epilepsy syndrome	1.57e-06	8.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.57e-06	8.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.56e-06	8e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.55e-06	7.95e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.53e-06	7.83e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.52e-06	7.81e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.52e-06	7.81e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.51e-06	7.72e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.5e-06	7.7e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—epilepsy syndrome	1.5e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.49e-06	7.63e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.49e-06	7.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.48e-06	7.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TH—epilepsy syndrome	1.48e-06	7.59e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAT—epilepsy syndrome	1.48e-06	7.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.47e-06	7.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TH—epilepsy syndrome	1.47e-06	7.52e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.44e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.44e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—epilepsy syndrome	1.44e-06	7.36e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.39e-06	7.13e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.36e-06	6.99e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.36e-06	6.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	6.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.34e-06	6.88e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—epilepsy syndrome	1.34e-06	6.85e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.33e-06	6.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.33e-06	6.79e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	6.72e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAT—epilepsy syndrome	1.29e-06	6.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	6.61e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.24e-06	6.37e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	6.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.22e-06	6.28e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.22e-06	6.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.21e-06	6.21e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.21e-06	6.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.2e-06	6.17e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.2e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	6.08e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.18e-06	6.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.18e-06	6.03e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AGT—epilepsy syndrome	1.17e-06	6e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.17e-06	6e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.17e-06	6e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.15e-06	5.91e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—epilepsy syndrome	1.15e-06	5.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.14e-06	5.87e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.1e-06	5.65e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.09e-06	5.6e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—epilepsy syndrome	1.09e-06	5.6e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.09e-06	5.57e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.07e-06	5.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.05e-06	5.39e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.04e-06	5.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.03e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.03e-06	5.28e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.03e-06	5.28e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AGT—epilepsy syndrome	1.03e-06	5.26e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—epilepsy syndrome	1.01e-06	5.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—epilepsy syndrome	9.91e-07	5.08e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—epilepsy syndrome	9.86e-07	5.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.82e-07	5.03e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—epilepsy syndrome	9.74e-07	5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.71e-07	4.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TH—epilepsy syndrome	9.68e-07	4.96e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.67e-07	4.96e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	9.58e-07	4.91e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.47e-07	4.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	9.39e-07	4.81e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	9.34e-07	4.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	9.13e-07	4.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—epilepsy syndrome	9.04e-07	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.85e-07	4.54e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—epilepsy syndrome	8.64e-07	4.43e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.14e-07	4.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.08e-07	4.14e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	8.07e-07	4.14e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	8.07e-07	4.13e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.97e-07	4.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	7.91e-07	4.05e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—epilepsy syndrome	7.87e-07	4.04e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—epilepsy syndrome	7.86e-07	4.03e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.75e-07	3.97e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.42e-07	3.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	7.35e-07	3.77e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.21e-07	3.7e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	7.06e-07	3.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.89e-07	3.53e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.49e-07	3.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	6.43e-07	3.3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.32e-07	3.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.19e-07	3.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.32e-07	2.73e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.85e-07	2.49e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.69e-07	2.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.59e-07	2.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.24e-07	2.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.97e-07	2.04e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—epilepsy syndrome	3.95e-07	2.03e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.55e-07	1.82e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.46e-07	1.77e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.26e-07	1.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.23e-07	1.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.13e-07	1.09e-05	CbGpPWpGaD
